Karen Huntsman helped build a movement against cancer—one defined by compassion, vision, and hope. Her legacy will continue to shape care, research, and the lives of patients and families.
In Southeast Idaho, a new affiliation brings advanced clinical expertise, research, and treatment options closer to home for these patients and families.
A clinical trial led by Neeraj Agarwal, MD, FASCO, found that a combination prostate cancer therapy could slow disease progression for patients with certain gene alterations, including BRCA.
Huntsman Cancer Institute’s CEO joined a select group of national cancer leaders to discuss opportunities to advance cancer research, improve rural care, and strengthen U.S. leadership.
After a rare cancer diagnosis threatened her future, Morgan Marietti fought through treatment while preserving her dream of motherhood—ultimately finding hope, healing, and new meaning in becoming a parent.
National Cancer Institute Director Anthony Letai, MD, PhD, visited Huntsman Cancer Institute earlier this month, praising its research excellence, rural outreach, and expanded access to care.
From the seat of an excavator, cancer survivor Noah Reeb officially broke ground on an expansion that will double capacity, bring lifesaving care closer to home, and advance research, education...
After her 9-year-old son was diagnosed with stage 4 brain cancer, Kelsey Embrey experienced the fear, hope, and healing she had spent years helping others navigate.
Don Milligan, MBA, chief administrative officer of the Cancer Hospital at Huntsman Cancer Institute and University of Utah Health, leaves a lasting legacy of patient‑centered leadership and operational excellence.
What if cancer cells are using a signaling shortcut we’ve been missing? Scientists uncovered a mechanism in a key cell-to-cell communication system—insight that could point to more effective therapies.
Janis Gunnell’s passion for nursing is rooted in service and education, helping empower clinical staff deliver compassionate, high-quality care to every patient.
Utah’s $33 million investment fuels AI, advanced computing, and secure data innovation—strengthening health research and discovery statewide through leadership at the University of Utah and Huntsman Cancer Institute.
Graduate researchers Mumtaz Shirin and Lisa Shakachite share their experiences at the Annual Meeting of the American Association for Cancer Research—a major conference of 20,000 scientists.
Gamblin explains how cancer research and technological advances have made complex operations like liver surgery safer, offering hope for today’s patients and confidence in where care and discovery are headed.
Firefighters face hidden cancer risks long after the fire is out. A new comprehensive cancer screening initiative is helping doctors find cancer earlier and better understand occupational risk factors.
Fred Roth’s story highlights the power of caregivers, clinical teams, and connection. The former leukemia patient shares his experience, honesty, and hope with others on a daily basis.
After vocal cord cancer and recurrence, pilot Bev Barge faced losing his voice. However, an innovative surgery preserved his voice, restored his life, and redefined what was possible.
A few dedicated employees work around the clock, behind the scenes, operating the cyclotrons which make PET scans possible, ensuring uninterrupted cancer diagnosis and care across Utah and beyond.
Facing breast cancer surgery can feel scary and overwhelming. A technology called SAVI SCOUT is making lumpectomies (or partial removal of the breast) easier for patients and surgeons.
To anyone feeling overwhelmed or lost, please know you are not alone. You are loved. There are others you love, and your love is extremely important to them.
Cancer survivorship can lead to uncertainty, identity shifts, and fear of recurrence. Supportive survivorship resources help people rebuild confidence, reconnect, and find meaning in a new phase of life.
The first three patients have been treated in an early-stage clinical trial of a new radiopharmaceutical medicine at Huntsman Cancer Institute, marking an important step in developing new cancer therapies.
